Allen & Overy advises JP Morgan Securities in connection with capital increase of MorphoSys
Allen & Overy has advised JP Morgan Securities in connection with the capital increase of MorphoSys, raising gross proceeds of approximately €84m (£71m) in a private placement via an accelerated book-building procedure.
MorphoSys has issued 1,514,066 new shares from authorised capital to international institutional investors at a price of €55.76 per share. The offering represents approximately 6.3 per cent of the registered pre-transaction share capital of MorphoSys.
Deutsche Bank and JP Morgan Securities acted as joint bookrunners in relation to the transaction.
The Allen & Overy team comprised partners Dr Oliver Seiler (international capital markets, Frankfurt) and Gernot Wagner (US corporate finance, Frankfurt), as well as senior associate Dr Camilla Kehler-Weiß and associate David Rath (both international capital markets, Frankfurt).
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
A new Luxembourg act on the immobilisation of bearer shares and units was published in the Luxembourg Official Gazette on 14 August 2014.
OFAC has issued revised guidance relating to the status of entities owned by individuals or entities whose interests in property are blocked under executive orders.
Analysis from The Lawyer
At the time of its launch Accutrainee was described as a revolutionary change to the training model. Has it proved to be so? Not really.
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.